Page 19 - Multiple Sclerosis Ms News Today

When treating pain in multiple sclerosis, a specialist is urging colleagues to think outside the box - especially since pain can evolve over time due to changes in MS and related conditions.

The brain cells that nourish neurons also release toxins that can destroy the very cells they feed, leading to neurodegenerative diseases.

A new indirect comparison of three new FDA-approved treatment options for aquaporin4+ neuromyelitis optica has suggested that eculizumab is the most effective. But many limitations have been raised.

A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.

In a recent study of patients with early relapsing-remitting MS or clinically isolated syndrome, almost two thirds of confirmed disability accumulation occurred independently of relapses.

Once regarded with suspicion, exercise appears to have real benefits for patients with MS.

Simply imagining movement can help improve walking and balance in patients with MS.

Time to confirmed disability worsening was longer in patients who received dimethyl fumarate, compared with those who received teriflunomide, in an analysis of real-world data.

Autologous hematopoietic stem cell transplantation for the treatment of active secondary progressive MS is associated with better disability outcomes than other immunotherapies, a new Italian study suggests.

The first European consensus on vaccination in patients with MS has been developed by the European Committee for Treatment and Research in Multiple Sclerosis and the European Academy of Neurology.